Trial Profile
Assessment of the comparative effect of donepezil 10mg/d and placebo on radiological and biological markers in patients with amnestic mild cognitive impairment
Status:
Not yet recruiting
Phase of Trial:
Phase III
Latest Information Update: 05 Aug 2011
Price :
$35
*
At a glance
- Drugs Donepezil (Primary)
- Indications Alzheimer's disease; Mild cognitive impairment
- Focus Therapeutic Use
- 20 Jul 2011 Results presented at the 2011 International Conference on Alzheimer's Disease.
- 20 Oct 2008 New trial record.